跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,956 条关于
“Pyruvate Kinase Deficiency”
全部
10,956
临床试验
7,495
药物
600
机构
196
资讯
2,665
5年前
Agios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
2年前
FDA Approves Pyrukynd as First Treatment for Pyruvate Kinase Deficiency
4年前
FDA Approves Pyrukynd (mitapivat) for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency
去年
Avanzanite Partners with Agios to Commercialize First-in-Class Pyruvate Kinase Activator Across Europe
去年
Phase 3 RISE UP Trial of Mitapivat in Sickle Cell Disease Completes Enrollment
去年
Agios' Mitapivat Receives Positive CHMP Opinion for Thalassemia Treatment in Europe
去年
Agios Pharmaceuticals Addresses Safety Concerns as PYRUKYND Receives Saudi Approval for Thalassemia
去年
Agios Pharmaceuticals Reports Strong Q3 2024 Driven by Vorasidenib Milestone and Mitapivat Progress
去年
Agios Pharmaceuticals Advances Tebapivat for Sickle Cell Disease and Hemolytic Anemias
去年
EMA Initiates Review of Rocket Pharma's Gene Therapy for Fanconi Anaemia
第 1 页，共 267 页
上一页
下一页
